Table 3 Results of univariate analysis of over survival (OS) for patients with TNBC
Characteristics | HR | 95% CI | P value |
|---|---|---|---|
miR-17-5p | 0.08 | 0.02–0.31 | 2.32 × 10−4 |
ETV1 | 4.10 | 1.07–15.68 | 0.040 |
Age (y) | |||
  ≤ 50 (ref) |  |  |  |
  > 50 | 1.95 | 1.09–3.49 | 0.025 |
Tumour Size | |||
  ≤ 2 cm (ref) |  |  |  |
  > 2 cm | 1.57 | 0.70–1.92 | 0.276 |
Pathological Type | |||
 IDC (ref) |  |  |  |
 Others | 0.68 | 0.24–1.92 | 0.472 |
Lymph node metastasis | |||
 0–4 (ref) |  |  |  |
 5–8 | 1.68 | 0.89–3.17 | 0.108 |
  ≥ 9 | 1.44 | 0.62–3.33 | 0.391 |
TNM | |||
 I + II (ref) |  |  |  |
 III | 3.52 | 1.69–7.34 | 7.60 × 10−4 |